(Total Views: 375)
Posted On: 06/26/2019 11:15:44 AM
Post# of 54
$TBIO News Article - Translate Bio Announces FDA Clearance to Proceed with a Single-ascending Dose (SAD) Phase 1/2 Clinical Trial for Ornithine Transcarbamylase (OTC) Deficiency https://marketwirenews.com/news-releases/tran...16372.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
